Back to Search Start Over

Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-mediated Hypercalcemia

Authors :
Jenae Osborne
Shafaq Khairi
David T. Hughes
Tobias Else
Gregory T. Clines
Michelle F. Jacobs
Barbra S. Miller
Source :
Horm Cancer
Publication Year :
2020

Abstract

Primary hyperparathyroidism (pHPT) is associated with familial syndromes such as multiple endocrine neoplasia type 1 (MEN1), 2A (MEN2A), MEN-like syndromes (CDKN1B), and CDC73-related disorder (hyperparathyroidism – jaw tumor syndrome (HPJT)). Familial hypocalciuric hypercalcemia (FHH) caused by CASR variants is an important differential diagnosis for pHPT. In order to evaluate the contribution of hereditary causes to pHPT in patients encountered in a specialized clinic, we conducted a retrospective study on patients with pHPT that underwent germline genetic testing. We evaluated 46 patients referred to a Cancer Genetics Clinic. Reasons for referral were young age (age

Details

Language :
English
Database :
OpenAIRE
Journal :
Horm Cancer
Accession number :
edsair.doi.dedup.....6df355a8e8206354150b7795686e3fd0